Patents by Inventor Andrew Ho Kang

Andrew Ho Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APLs for treating arthritis
    Patent number: 9144595
    Abstract: One embodiment of a therapeutic composition comprises one or more APLs, e.g., APL A12, for treating diseases or disorders related to arthritis, including rheumatoid arthritis. Another embodiment includes a method of inducing a Th2-type cytokine secretion profile in a mammal, including administering a therapeutic amount of A12 analog peptide. Another embodiment includes a method for generating functional T regulatory cells, the method including administering a therapeutic amount of APL A12 to a RA patient.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: September 29, 2015
    Assignee: University of Tennessee Research Foundation
    Inventors: Arnold E. Postlethwaite, Andrew Ho Kang, Linda K. Myers
  • APLS FOR TREATING ARTHRITIS
    Publication number: 20140113867
    Abstract: One embodiment of a therapeutic composition comprises one or more APLs, e.g., APL A12, for treating diseases or disorders related to arthritis, including rheumatoid arthritis. Another embodiment includes a method of inducing a Th2-type cytokine secretion profile in a mammal, including administering a therapeutic amount of A12 analog peptide. Another embodiment includes a method for generating functional T regulatory cells, the method including administering a therapeutic amount of APL A12 to a RA patient.
    Type: Application
    Filed: October 1, 2013
    Publication date: April 24, 2014
    Inventors: Arnold E. Postlethwaite, Andrew Ho Kang, Linda K. Myers